TLV:KMDA
Kamada Ltd. · TLV · Healthcare · ILS · FY for 2024
Figures on this page computed 2026-11-08 12:27 UTC
Last close
n/aILA
Market data
26.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- ILA
- computed
- Computed from the filing for 2024
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- ILA
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
9.0%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- ILA
- Computed from the filing for 2024
- Computed from the filing for 2024
22.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- ILA
- Computed from the filing for 2024
- Computed from the filing for 2024
0.04Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- ILA
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- ILA
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth74.6%81 of 100, above its sector
- Returns on capital5.6%63 of 100, above its sector
- Margins43.5%72 of 100, above its sector
- Price26.9x50 of 100, above its sector
- Safety0.0478 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2024
- Sales1.06x
Its own average over 2 years, 151.7M.
- Profit1.27x
Its own average over 2 years, 11.4M.
- Free cash flow2.09x
Its own average over 2 years, 17.7M.
- Debt1.11x
Its own average over 2 years, 9.9M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 2.09 times.
Sales is 1.06 times its own 2-year average; Profit is 1.27 times its own 2-year average; Free cash flow is 2.09 times its own 2-year average; Debt is 1.11 times its own 2-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2024
Sales against its own 2-year average1.06
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- USD
Profit against its own 2-year average1.27
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- USD
Free cash flow against its own 2-year average2.09
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- USD
Debt against its own 2-year average1.11
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- USD
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- ILA